Financial Gravity Asset Management, Inc.
Position in JNJ — Johnson & Johnson
CIK 1741736
Lakeway, TX
Position in JNJ
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,733,087
+$572,547 QoQ
Shares Held
15,272
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Financial Gravity Asset Management, Inc. holds $16,585,205 across 10 Drug Manufacturers - General names. JNJ ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
47,971 | $7,327,570 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,272 | $3,733,087 | |
| 3 | AZN |
Astrazeneca PLC
|
16,601 | $3,274,049 | |
| 4 | NVO |
Novo Nordisk A S
|
51,858 | $1,905,781 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,478 | $205,988 | |
| 6 | ABBV |
AbbVie Inc.
|
336 | $73,076 | |
| 7 | LLY |
ELI LILLY & Co
|
49 | $45,068 | |
| 8 | MRK |
Merck & Co., Inc.
|
100 | $12,029 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,733,087 | 15,272 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,160,540 | 15,272 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,691,185 | 14,514 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $2,183,449 | 13,166 | Shares | Sole | 2025-04-30 | |
| 2024-06-30 | $1,694,432 | 11,593 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,600,882 | 10,120 | Shares | Sole | 2024-06-26 | |
| 2023-12-31 | $1,586,052 | 10,119 | Shares | Sole | 2024-06-26 | |
| 2023-09-30 | $12,186,668 | 124,848 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $930,553 | 5,622 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $646,701 | 5,380 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $267,448 | 1,514 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $713,965 | 5,269 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,588,125 | 15,587 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $919,242 | 6,187 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $982,677 | 6,405 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $506,909 | 3,139 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,122,702 | 6,815 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,010,587 | 6,149 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $549,631 | 3,493 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $150,517 | 1,148 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||